eXoZymes (NASDAQ:EXOZ) Releases Quarterly Earnings Results

eXoZymes (NASDAQ:EXOZ) posted its quarterly earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, FiscalAI reports.

eXoZymes Stock Down 2.2%

NASDAQ:EXOZ traded down $0.09 during midday trading on Friday, hitting $3.91. 20,051 shares of the company were exchanged, compared to its average volume of 7,208. The company has a fifty day simple moving average of $5.21 and a 200 day simple moving average of $7.48. eXoZymes has a fifty-two week low of $3.24 and a fifty-two week high of $16.90. The company has a current ratio of 3.81, a quick ratio of 3.81 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $36.36 million, a PE ratio of -3.29 and a beta of 3.34.

Hedge Funds Weigh In On eXoZymes

An institutional investor recently bought a new position in eXoZymes stock. BlackRock Inc. bought a new position in shares of eXoZymes Inc. (NASDAQ:EXOZ) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 9,610 shares of the company’s stock, valued at approximately $81,000. BlackRock Inc. owned approximately 0.10% of eXoZymes as of its most recent filing with the Securities and Exchange Commission (SEC).

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on EXOZ. Weiss Ratings reiterated a “sell (e+)” rating on shares of eXoZymes in a research note on Wednesday, August 26th. Zacks Research raised shares of eXoZymes to a “hold” rating in a research report on Friday, October 2nd. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, eXoZymes presently has a consensus rating of “Reduce”.

eXoZymes Company Profile

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.